Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07174349Phase 4Recruiting
Phase 4, randomised trial of tamsulosin in urinary retention (2 arms), sponsored by Mayo Clinic. Primary endpoint: Number of incidences of Postoperative urinary retention. Started Oct 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07174349.